Pathways' Pick of the Week: CMS Seeks Diabetes Device Endpoints Guidance
CMS aims to identify diabetes endpoints. Excerpted from Pathways' Picks March 27: Dx Debate, Medicare Diabetes Endpoints, EU Expert Panels, and Global Picks.
MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter BrowseCMS aims to identify diabetes endpoints. Excerpted from Pathways' Picks March 27: Dx Debate, Medicare Diabetes Endpoints, EU Expert Panels, and Global Picks.
Artificial intelligence has the potential to drive better outcomes and greater systemic efficiencies in orthopedics, but it is not yet ready for prime-time, according to speakers at AAOS 2024. Excerpted from our recent feature article, AAOS 2024 Takeaways.
FDA issues new Q-Sub guidance. Excerpted from Pathways’ Picks March 20: Diagnostics Updates, AI Advocacy, China Documents, and More.
The EU adds an extra round to its ongoing “scientific advice” pilot for high-risk devices. Excerpted from Pathways’ Picks April 2: EU Advice Pilot Extends, NTAP Watch, FDA Standards Scheme Starts Small.